{
  "ptid_time": "131_S_0123_2008-05-08",
  "img_path": "/data/qiuhui/data/adni/images/131_S_0123/2008-05-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 33,038 mm³, 14.2% below the reference mean. With a Z-score of -0.34 (36.7th percentile), this represents normal volume ; hippocampal volume measures 5,550 mm³, 26.6% below the reference mean. With a Z-score of -2.59 (0.5th percentile), this represents significant atrophy; whole brain volume measures 870,455 mm³, 19.4% below the reference mean. With a Z-score of -2.51 (0.6th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,159 mm³, 47.3% below the reference mean. With a Z-score of -3.21 (0.1th percentile), this represents profound atrophy; fusiform gyrus volume measures 14,900 mm³, 20.9% below the reference mean. With a Z-score of -1.78 (3.7th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 14,135 mm³, 33.8% below the reference mean. With a Z-score of -3.03 (0.1th percentile), this represents profound atrophy. ",
  "text_data": "Age is 75.3 years. Gender is Male. Education: 20 years. MMSE: 29.0. Logical Memory: 19.0. Laboratory findings: Total Bilirubin: 1.70 (profound elevated); Direct Bilirubin: 0.40 (profound elevated); Phosphorus: 2.50 (significant reduced). APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, middle temporal gyrus) with Z-scores well below the 5th percentile, suggesting neurodegeneration. However, the MMSE score of 29 is within the normal range, and the absence of APOE4 reduces genetic risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype given hippocampal/entorhinal atrophy, but high-functioning clinically).  \n\n**Confidence:** **Medium** (conflicting findings—severe atrophy on imaging but preserved cognition; longitudinal follow-up or additional biomarkers would strengthen certainty).  \n\n*Note:* If CSF or amyloid PET confirms Alzheimer’s pathology, progression to dementia is likely. Current clinical presentation suggests MCI due to the intact MMSE.",
  "timestamp": "2025-07-26T14:59:18.055615"
}